Invention Grant
- Patent Title: Monoclonal antibodies against KIR2DS1
-
Application No.: US15507698Application Date: 2015-08-27
-
Publication No.: US10429394B2Publication Date: 2019-10-01
- Inventor: Katsumi Maenaka , Kimiko Kuroki , Hiroshi Maita , Hideo Fukuhara
- Applicant: National University Corporation Hokkaido University
- Applicant Address: JP Hokkaido
- Assignee: National University Corporation Hokkaido
- Current Assignee: National University Corporation Hokkaido
- Current Assignee Address: JP Hokkaido
- Agency: K&L Gates LLP
- Agent Louis C. Cullman; David Diamond
- Priority: JP2014-176094 20140829
- International Application: PCT/JP2015/074295 WO 20150827
- International Announcement: WO2016/031936 WO 20160303
- Main IPC: G01N33/577
- IPC: G01N33/577 ; C07K16/28 ; C12N5/10 ; C12N15/02 ; G01N33/53 ; A61K39/395 ; C12N15/09 ; C07K16/00 ; C07K1/00

Abstract:
A monoclonal antibody to KIR2DS1 or a fragment containing an antigen-binding region thereof has VL having an amino acid sequence of SEQ ID NO: 1 or an amino acid sequence having the same amino acid sequence as the amino acid sequence except that one or several amino acids are conservatively substituted as CDR1, having an amino acid sequence of SEQ ID NO: 2 or an amino acid sequence having the same amino acid sequence as the amino acid sequence except that one or several amino acids are conservatively substituted as CDR2, and having an amino acid sequence of SEQ ID NO: 3 or an amino acid sequence having the same amino acid sequence as the amino acid sequence except that one or several amino acids are conservatively substituted as CDR3; and VH having an amino acid sequence of SEQ ID NO: 4 or SEQ ID NO: 5 or an amino acid sequence having the same amino acid sequence as the amino acid sequence except that one or several amino acids are conservatively substituted as CDR1, having an amino acid sequence of SEQ ID NO: 6 or an amino acid sequence having the same amino acid sequence as the amino acid sequence except that one or several amino acids are conservatively substituted as CDR2, and having an amino acid sequence of any one selected from the group consisting of SEQ ID NO: 7, SEQ ID NO: 8, and SEQ ID NO: 9 or an amino acid sequence having the same amino acid sequence as the amino acid sequence except that one or several amino acids are conservatively substituted as CDR3.
Public/Granted literature
- US20170350892A1 MONOCLONAL ANTIBODY AGAINST KIR2DS1 Public/Granted day:2017-12-07
Information query
IPC分类: